Growth Metrics

GeneDx Holdings (WGS) Change in Inventory (2020 - 2026)

GeneDx Holdings has reported Change in Inventory over the past 7 years, most recently at -$1.7 million for Q1 2026.

  • Quarterly Change in Inventory fell 183.12% to -$1.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$285000.0 through Mar 2026, down 116.38% year-over-year, with the annual reading at $3.4 million for FY2025, 32.92% up from the prior year.
  • Change in Inventory was -$1.7 million for Q1 2026 at GeneDx Holdings, down from $3.4 million in the prior quarter.
  • Over five years, Change in Inventory peaked at $3.4 million in Q4 2025 and troughed at -$7.6 million in Q4 2022.
  • The 5-year median for Change in Inventory is -$293000.0 (2023), against an average of $59235.3.
  • The largest YoY upside for Change in Inventory was 640.97% in 2025 against a maximum downside of 379.25% in 2025.
  • A 5-year view of Change in Inventory shows it stood at -$7.6 million in 2022, then surged by 96.14% to -$293000.0 in 2023, then surged by 254.95% to $454000.0 in 2024, then soared by 640.97% to $3.4 million in 2025, then crashed by 150.21% to -$1.7 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Change in Inventory are -$1.7 million (Q1 2026), $3.4 million (Q4 2025), and -$1.3 million (Q3 2025).